The Cataract Surgery Devices Market is led by North America, which accounted for approximately 35.5% of global revenue in 2025. The region benefits from established ophthalmic infrastructure, strong adoption of premium IOLs, and the continued expansion of ambulatory surgery centers.

Europe represents the second-largest regional market, with revenue of approximately USD 2.61 billion in 2025. Regulatory requirements and efforts to reduce surgical waiting lists are influencing purchasing decisions across European healthcare systems.

Asia-Pacific is the fastest-growing regional market, with a projected CAGR of 6.46%. Increasing healthcare investment, large cataract surgery backlogs, expanding ophthalmology infrastructure, and government-supported blindness-control programs are driving regional demand.

Major companies identified in the market include Alcon, Johnson & Johnson Vision, Bausch + Lomb, Carl Zeiss Meditec, HOYA Surgical Optics, Nidek, STAAR Surgical, Rayner, Ziemer Ophthalmic Systems, and Topcon Healthcare.

With the market projected to reach USD 14.78 billion by 2035, continued development of premium IOLs, femtosecond lasers, digital surgical planning, AI-assisted biometry, and ambulatory cataract-care models is expected to shape the future of the global cataract surgery devices industry.